US 11,925,433 B2
System and method for improving and adjusting PMC digital signals to provide health benefits to listeners
Mark Levinson, Geneva (CH)
Assigned to DANIEL HERTZ S.A., Geneva (CH)
Filed by DANIEL HERTZ S.A., Geneva (CH)
Filed on Jul. 17, 2020, as Appl. No. 16/932,235.
Prior Publication US 2022/0015633 A1, Jan. 20, 2022
Int. Cl. G16H 10/20 (2018.01); A61B 5/00 (2006.01); G06F 3/16 (2006.01); G10H 1/00 (2006.01); G10H 1/46 (2006.01); G10K 11/00 (2006.01); H03G 9/00 (2006.01)
CPC A61B 5/002 (2013.01) [A61B 5/0004 (2013.01); G06F 3/165 (2013.01); G10H 1/0041 (2013.01); G10H 1/46 (2013.01); G10K 11/002 (2013.01); G16H 10/20 (2018.01); H03G 9/005 (2013.01)] 11 Claims
OG exemplary drawing
 
1. A method of processing audio signals comprising:
receiving an analog audio signal as input from at least one source of audio signals;
performing a digital to analog conversion by converting the analog audio signal to a digital format;
performing sampling on the analog audio signal;
processing the digital converted audio signal using a digital system processor, having a computer processor and memory or circuitry, by applying an equalization, a reverberation and a volume setting that is measured to produce an audio output signal that has a more beneficial health response on at least one human physiological functions than an unprocessed PCM digital signal or a base measurement without any audio signal,
measuring the physiological functions of at least one listener using one or more bio-sensors attached to the at least one listener, the sensors configured to measure the at least one improved physiological function of the listener,
wherein the measuring of the physiological functions of the at least one listener using the attached bio-sensors includes measuring the bio-signal responses related to a central nervous system, a liver and a kidney functions of the listener.